-
Company Insights
Innovation and Patenting activity of Onward Holdings Co., Ltd. Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Onward Holdings Co., Ltd. Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OTA-201 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTA-201 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OTA-201 in Solid Tumor Drug Details: OTA-201 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OTA-201 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTA-201 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OTA-201 in Relapsed Multiple Myeloma Drug Details: OTA-201 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OTA-201 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTA-201 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OTA-201 in Refractory Multiple Myeloma Drug Details: OTA-201 is under development...
-
Product Insights
Broad River Energy Center
Broad River Energy Center is a thermal project located in South Carolina, United States. The project is owned by Onward Energy Inc. The project came online in 2000. Empower your strategies with our Broad River Energy Center report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
Mankato Combined Cycle Power Plant
Mankato Combined Cycle Power Plant is a thermal project located in Minnesota, United States. The project is owned by Onward Energy Inc and was developed by Calpine Corp. The project came online in 2006. Empower your strategies with our Mankato Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Sector Analysis
China Baby Food Market Size and Share by Categories, Distribution and Forecast to 2028
China Baby Food Market Report Overview The China baby food market size was CNY94.8 billion ($14.1 billion) in 2022. The market is expected to garner a CAGR of less than 1% during 2022-2028. China Baby Food Market Outlook, 2022-2028 (CNY Billion) Buy the Full Report for More Insights on the China Baby Food Market Forecast, Download A Free Report Sample The China baby food market research report puts together multiple data sources to provide a comprehensive baby food sector overview...
-
Product Insights
Clinical Decision Support Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clinical Decision Support Systems Pipeline Market Report Overview The Clinical Decision Support Systems (CDSS) are software tools that assist healthcare professionals with decision-making. The software consolidates a medical knowledge base with patient information to produce case-specific advice. The Clinical Decision Support Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the...
-
Sector Analysis
Germany Forecourt Market Size and Forecast by Segment and Fuel Retailer Profiles to 2027
Germany Forecourt Market Report Overview The total forecourt sales in Germany were estimated at EUR 100.52 billion in 2022. The outlook for total forecourt value sales looks promising for 2023–27 and is expected to record a CAGR of more than 3% during the projected period. From 2023 onwards, fuel will understandably maintain the largest share of revenue but with a more diversified fuel mix. With electric vehicles (EVs) becoming more popular, there is expected to be a larger presence of...
-
Product Insights
Clinical Trials – Precision and Personalized Medicine
This report provides analysis of clinical research involving precision and personalized medicines and identifies trends throughout the years. The terms precision and personalized medicine are often used interchangeably as they refer to similar types of treatment. They both define the stratification of patients within a disease segment using their genomic and phenotypic variations to find targeted therapies. This is an alternative to the traditional process of drug design, which typically follows a one-size-fits all approach. Precision and personalized medicine is...